EBV-infected Cell Lineage by EBER Double-staining as a Diagnostic and Prognostic Clue in Pediatric EBV-related Lymphoproliferative Disorders: A Japanese Central Pathology Cohort Study
The Journal of Infectious Diseases · 23.10.2026
DOI: 10.1093/infdis/jiag523 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 23.10.2026. Verfasst von Rintaro Ono und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Practical Research for Innovative Cancer Control, National Center for Child Health and Development of Japan.
Abstract (Originalsprache)
We retrospectively analyzed 36 children with Epstein–Barr virus-related lymphoproliferative disorder (EBV-LPD) from the Japan Children's Cancer Group (2006–2021), focusing on diagnostically challenging lesions not definitively classified as lymphoma. Using EBER in situ hybridization double staining, we confirmed EBV infection primarily in T/NK cells (EBV-T/NK-LPD, n = 17) or B cells (EBV-B-LPD, n = 16). Lymphoid follicle architecture was effaced in EBV-T/NK-LPD (89%) and EBV-B-LPD (54%). 5-year overall survival was lower for EBV-T/NK-LPD (59%) than EBV-B-LPD (93%). Determining the EBV-infected cell lineage enables clinically relevant classification and risk stratification, and can be applied to archival specimens, including lesions initially interpreted as reactive.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
- Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Pediatrics, National Defense Medical College, Saitama, Japan.
- Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatric Hematology and Oncology Research, National Center for Child health and Development, Tokyo, Japan.
- Department of Pathology, Shizuoka Children's Hospital, Shizuoka, Japan.
ORCID-Profile: Rintaro Ono, Kenichi Sakamoto, Kunihiko Moriya
Förderung
- Japan Agency for Medical Research and Development
- Practical Research for Innovative Cancer Control
- National Center for Child Health and Development of Japan
Zitieren
APA
Ono, R., Sakamoto, K., Moriya, K., Hoshino, A., Ohki, K., Kiyokawa, N., Iwafuchi, H., Yoshioka, T., Kanegane, H., Imadome, K. I., Sekimizu, M., Shioda, Y., & Nakazawa, A. (2026). EBV-infected Cell Lineage by EBER Double-staining as a Diagnostic and Prognostic Clue in Pediatric EBV-related Lymphoproliferative Disorders: A Japanese Central Pathology Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag523
Vancouver
Ono R, Sakamoto K, Moriya K, Hoshino A, Ohki K, Kiyokawa N, et al. EBV-infected Cell Lineage by EBER Double-staining as a Diagnostic and Prognostic Clue in Pediatric EBV-related Lymphoproliferative Disorders: A Japanese Central Pathology Cohort Study. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag523
BibTeX
@article{Ono2026,
author = {Ono, Rintaro and Sakamoto, Kenichi and Moriya, Kunihiko and Hoshino, Akihiro and Ohki, Kentaro and Kiyokawa, Nobutaka and Iwafuchi, Hideto and Yoshioka, Takako and Kanegane, Hirokazu and Imadome, Ken-Ichi and Sekimizu, Masahiro and Shioda, Yoko and Nakazawa, Atsuko},
title = {EBV-infected Cell Lineage by EBER Double-staining as a Diagnostic and Prognostic Clue in Pediatric EBV-related Lymphoproliferative Disorders: A Japanese Central Pathology Cohort Study},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag523}
}
EUVIMED